Aditxt Inc. (NASDAQ:ADTX) — Market Cap & Net Worth
Market Cap & Net Worth: Aditxt Inc. (ADTX)
Aditxt Inc. (NASDAQ:ADTX) has a market capitalization of $2.00 Million ($2.00 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30105 globally and #6123 in its home market, demonstrating a -5.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aditxt Inc. 's stock price $0.01 by its total outstanding shares 997976542 (997.98 Million). Also see ADTX total assets for a full breakdown of the balance sheet.
Aditxt Inc. Market Cap History: 2020 to 2026
Aditxt Inc. 's market capitalization history from 2020 to 2026. Data shows change from $83.03 Billion to $6.79 Million (-81.00% CAGR). Also see ADTX cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Aditxt Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #881 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2806 of 3165 |
Weight: Aditxt Inc. 's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aditxt Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aditxt Inc. 's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Aditxt Inc. share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
260660.85x
Aditxt Inc. 's market cap is 260660.85 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $21.40 Billion | $105.03K | -$46.37 Million | 203749.35x | N/A |
| 2022 | $46.09 Billion | $933.72K | -$27.65 Million | 49362.54x | N/A |
| 2023 | $264.66 Billion | $645.18K | -$32.38 Million | 410218.88x | N/A |
| 2024 | $189.42 Million | $133.99K | -$34.45 Million | 1413.71x | N/A |
| 2025 | $832.81 Million | $3.19K | -$41.71 Million | 260660.85x | N/A |
Competitor Companies of ADTX by Market Capitalization
Companies near Aditxt Inc. in the global market cap rankings as of September 18, 2026. Review tangible net worth ratio of Aditxt Inc. to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Aditxt Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Aditxt Inc. Historical Marketcap From 2020 to 2026
Between 2020 and today, Aditxt Inc. 's market cap moved from $83.03 Billion to $ 6.79 Million, with a yearly change of -81.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.79 Million | -99.19% |
| 2025 | $832.81 Million | +339.67% |
| 2024 | $189.42 Million | -99.93% |
| 2023 | $264.66 Billion | +474.22% |
| 2022 | $46.09 Billion | +115.37% |
| 2021 | $21.40 Billion | -74.23% |
| 2020 | $83.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Aditxt Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.00 Million USD |
| MoneyControl | $2.00 Million USD |
| MarketWatch | $2.00 Million USD |
| marketcap.company | $2.00 Million USD |
| Reuters | $2.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aditxt Inc.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body nat… Read more